The Organoid group at the Hubrecht Institute have identified a new link between FBXW7 mutations and EGFR signaling activity. The FBXW7 gene is commonly mutated in colorectal cancer and such mutations ...
A groundbreaking phase 2 clinical trial has unveiled promising advancements in the treatment landscape for non-small cell lung cancer (NSCLC), ...
Ivonescimab's BLA acceptance is a milestone for PD-1/VEGF bispecific antibodies in the U.S., potentially transforming second-line NSCLC treatment post-TKI failure. The HARMONi trial showed ivonescimab ...
Morning Overview on MSN
Scientists finally crack why some cancer treatments suddenly stop working
After months of shrinking scans, the tumors suddenly came roaring back. Oncologists have seen this pattern for years in ...
Cell signaling is crucial for cells to communicate and function correctly. Disruptions in these pathways, caused by genetic mutations or environmental factors, can lead to uncontrolled cell growth, ...
Older adults living with heart failure with preserved ejection fraction (HFpEF) are frequently labeled as having chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results